CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-18 | Kama Gulsen Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +106,000 | 106,000 | ||
| 2023-06-14 | Mamuszka Hannah Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | Rajkovic Aleksandar Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | Luderer Albert Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | Linney Yvonne Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | Wong Vincent Jung-Fai Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | Vuori Kristiina MD Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-14 | BARKER DAVID L Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-06-13 | Mamuszka Hannah Director | Purchase | +65,789 | $0.76 | $50K | 65,789 |
| 2023-05-16 | Holmlin R. Erik President and CEO | Purchase | +15,000 | $0.64 | $10K | 806,474 |
| 2023-05-12 | Stewart Christopher P. Chief Financial Officer | Purchase | +50,000 | $0.67 | $33K | 281,373 |
| 2023-05-12 | OLDAKOWSKI MARK Chief Operating Officer | Shares withheld for taxes | −41,496 | $0.66 | $27K | 297,842 |
| 2023-05-12 | Holmlin R. Erik President and CEO | Shares withheld for taxes | −50,141 | $0.66 | $33K | 791,474 |
| 2023-02-15 | Holmlin R. Erik President and CEO | Grant or award | +300,000 | 841,615 | ||
| 2023-02-15 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +1,400,000 | 1,400,000 | ||
| 2023-02-15 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award | +120,000 | 339,338 | ||
| 2023-02-15 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +560,000 | 560,000 | ||
| 2023-02-15 | Chaubey Alka Chief Medical Officer | Grant or award | +120,000 | 124,794 | ||
| 2023-02-15 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +560,000 | 560,000 |
Page 5 of 14 · 266 trades